Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma

DOI: 10.4143/crt.2015.466

Keywords: Bevacizumab, Glioma, High-grade glioma, Glioblastoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text